More to discover Hengrui Medicine in the Basel Area

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=P4Y51WXnGw4

Hengrui Medicine is one of the top 30 life sciences companies in the world. In China, where Hengrui was founded, it is the largest pharmaceutical company by market value by May 2021. • In 2020, Hengrui opened its Swiss subsidiary in Basel. The site will be dedicated to the clinical research and development of innovative drugs in Europe. Michael Van der Laan, Head of Clinical Development at Hengrui Europe Therapeutics Ltd, shares the company's success story on the decision to establish the global headquarter in Basel, Switzerland. • The Basel Area is Switzerland’s most dynamic business environment. There are numerous good reasons to establish a business in Switzerland but the Basel Area, situated on the border with France and Germany, will top the list in many categories: innovation and technology in Life Sciences, Healthcare, Digital Health, and Advanced Manufacturing, a liberal economic system, political stability, excellent education and healthcare systems, an outstanding infrastructure, a high standard of living, and a competitive tax system. • Jiangsu Hengrui Medicine was founded in 1970 in China. The company focuses on the development of cancer treatments. Further, it produces MedTech products, contrast agents, surgical medicines as well as prescription drugs for diabetes, pain management, and autoimmune diseases. • Basel Area Business Innovation assisted Hengrui in establishing its subsidiary. Our experienced, multilingual team provides free, confidential, and individually tailored services to help you successfully relocate or expand your business to the Basel Area. • Contact us: https://invest.baselarea.swiss/contac... • Read more about Basel Area Business Innovation: https://invest.baselarea.swiss/portfo... • Follow us on LinkedIn: / base... • 👉 Stay tuned #whybaselarea #investinbasel

#############################

New on site